|
Health Conditions
|
Gout
What is on the horizon?
PEG-uricase is a mammalian derived enzyme which may be useful in decreasing uric acid in patients with gout. This drug is currently being tested for its safety and efficacy. If the trials are favorable, then we may see PEG-uricase as a new therapy for gout.
Additionally, Lumiracoxib, a Cox-2 inhibitor like Celebrex, is currently in the late stages of testing. If trials go well we may see this drug utilized more often with gout.
Studies are being conducted with the use of low frequency sound waves to help relieve pain associated with gout. However, these studies are preliminary.
|
Note: The above information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist, or other healthcare professional. It is not intended to diagnose a health condition, but it can be used as a guide to help you decide if you should seek professional treatment or to help you learn more about your condition once it has been diagnosed.
|
|
What is on the horizon?
